Pnc Financial Services Group, Inc. Arcellx, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 45 shares of ACLX stock, worth $3,519. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 59
23.73%
Holding current value
$3,519
Previous $3,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
204Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$313 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$304 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$293 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$275 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$193 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.43B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...